TOWA Corporation provided consolidated earnings guidance for the year ending March 31, 2024. For the year, the company expects net sales of ¥51,000 million, operating profit of ¥8,160 million and profit attributable to owners of parent of ¥5,710 million or ¥228.22 basic earnings per share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11,290 JPY | +4.44% |
|
+4.54% | +58.35% |
06/06 | Luye Pharma's Japanese Partner Towa Files New Drug Application for Dementia Patch | MT |
21/05 | Jefferies Adjusts TOWA’s Price Target to 16,000 Yen From 12,000 Yen, Keeps at Buy | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.35% | 1.69B | |
+75.70% | 42.88B | |
+48.02% | 36.47B | |
-15.84% | 28.01B | |
+32.55% | 23.82B | |
-8.01% | 12.6B | |
+12.61% | 12.37B | |
+184.28% | 12.21B | |
+54.32% | 6.97B | |
-18.55% | 5.04B |
- Stock Market
- Equities
- 6315 Stock
- News TOWA Corporation
- TOWA Corporation provides consolidated earnings guidance for the year ending March 31, 2024